Johns Hopkins Rheumatology

Dr. Elisa H. Ignatius is an infectious diseases and clinical pharmacology specialist at the Johns Hopkins University School of Medicine. She is an expert in the care of patients with nontuberculous mycobacterial (NTM) infections, tuberculosis (TB), bronchiectasis, HIV/AIDS, and other general infectious diseases. Additionally, she provides teaching for medical students, residents, and fellows at the Johns Hopkins University School of Medicine.Dr. Ignatius earned her M.D. and completed Internal Medicine residency at Emory University School of Medicine. She also obtained a Masters of Science in the Control of Infectious Diseases from the London School of Hygiene and Tropical Medicine, where her research focused on drug-resistant tuberculosis in South Africa. After completing residency, she worked as a co-investigator on HIV prevention clinical trials in Atlanta, Georgia. She then came to Johns Hopkins University where she completed fellowships in both Infectious Diseases and Clinical Pharmacology.Dr. Ignatius’s research interests focus on treatment optimization strategies for mycobacterial infections (NTM and TB), including regimens of novel and standard drugs.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida.